FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but with fewer side effect...
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but with fewer side effect...
What's Your Reaction?
Subhashree
Hi, This is Subhi.
Welcome to my blog! I love to keep up with the latest news in healthcare, technology and media. Here you will find insightful articles that inform and interest you about the world around you. Join me as I drift between health and technology, and stay up-to-date!
